CLARK CAPITAL MANAGEMENT GROUP, INC. – Halozyme Therapeutics, Inc. Transaction History
CLARK CAPITAL MANAGEMENT GROUP, INC. portfolio value:
$1.32M
portfolio value
CLARK CAPITAL MANAGEMENT GROUP, INC. quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.48% | -162 shares | -157K | $39.54 | 33.60K |
| Q2 2022 | share | Increase | 0.00% | 33.76K shares | 1.48M | $44 | 33.76K |
| Q1 2022 | share | Decrease | -100.00% | -55.22K shares | -2.22M | $39.88 | 0 |
| Q4 2021 | share | Decrease | -4.58% | -2.65K shares | -134K | $40.32 | 55.22K |
| Q3 2021 | share | Increase | 0.00% | 57.87K shares | 2.35M | $40.68 | 57.87K |